UCB and Ferring Pharmaceuticals Announce Co-Promotion of CIMZIA[®] (certolizumab …
(WorldNews Belgium)

· Ferring joins with UCB to promote CIMZIA prefilled syringe for Crohn`s disease in the U.S. · Co-promotion strengthens commitment to patients living with Crohn`s disease by reaching more gastroenterologists while also continuing patient support programs · Ferring is expanding its focus in specialty areas within gastroenterology, demonstrating commitment to gut health · UCB is preparing for future launches in immunology, demonstrating commitment to patients with severe chronic diseases Brussels, Belgium and Parsippany, USA - July 7, 2020 (7:00 p.m. CET and 1:00 p.m. ET) - UCB and Ferring Pharmaceuticals Inc. today announced they have entered into a co-promotion agreement to commercialize the...